Skip to main content
icon for ¿Casos de sarampión en EE. UU. antes del 30 de abril?

¿Casos de sarampión en EE. UU. antes del 30 de abril?

icon for ¿Casos de sarampión en EE. UU. antes del 30 de abril?

¿Casos de sarampión en EE. UU. antes del 30 de abril?

abr 30

may 31

dic 31

abr 30

may 31

dic 31

$484,586 Vol.

30 abr 2026
Polymarket

$484,586 Vol.

Polymarket

1800

$171,324 Vol.

1%

1900

$75,371 Vol.

1%

1850

$27,907 Vol.

4%

2000

$57,926 Vol.

<1%

1,950

$35,557 Vol.

1%

2100

$16,839 Vol.

1%

2200

$38,552 Vol.

<1%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of the Centers for Disease Control and Prevention's (CDC) latest update on April 24 reflecting data through April 23, 2026, the U.S. has recorded 1,792 confirmed measles cases year-to-date, with 93% linked to 22 outbreaks across 37 jurisdictions plus 10 among international visitors—led by South Carolina (668 cases), Utah (425), and Texas (180). Weekly cases by rash onset have declined sharply from a January peak of 295 to just 7 in the week ending April 19, signaling a slowing outbreak amid intensified vaccination efforts and public health responses. Historical context shows this surpasses 2025's full-year total of 2,288 cases, driven by pockets of low vaccination coverage enabling sustained transmission (R0 around 12-18). Traders should note reporting lags of 1-4 weeks via the National Notifiable Diseases Surveillance System; final April 30 tallies may incorporate late notifications, with CDC's next weekly summary expected soon after.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$484,586
Fecha de finalización
30 abr 2026
Mercado abierto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of the Centers for Disease Control and Prevention's (CDC) latest update on April 24 reflecting data through April 23, 2026, the U.S. has recorded 1,792 confirmed measles cases year-to-date, with 93% linked to 22 outbreaks across 37 jurisdictions plus 10 among international visitors—led by South Carolina (668 cases), Utah (425), and Texas (180). Weekly cases by rash onset have declined sharply from a January peak of 295 to just 7 in the week ending April 19, signaling a slowing outbreak amid intensified vaccination efforts and public health responses. Historical context shows this surpasses 2025's full-year total of 2,288 cases, driven by pockets of low vaccination coverage enabling sustained transmission (R0 around 12-18). Traders should note reporting lags of 1-4 weeks via the National Notifiable Diseases Surveillance System; final April 30 tallies may incorporate late notifications, with CDC's next weekly summary expected soon after.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$484,586
Fecha de finalización
30 abr 2026
Mercado abierto
Mar 27, 2026, 1:49 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. antes del 30 de abril?" es un mercado de predicción en Polymarket con 9 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "1750" con 100%, seguido de "1775" con 100%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 100¢ implica que el mercado colectivamente asigna una probabilidad de 100% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "¿Casos de sarampión en EE. UU. antes del 30 de abril?" ha generado $484.6K en volumen total de trading desde que el mercado se lanzó el Mar 24, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "¿Casos de sarampión en EE. UU. antes del 30 de abril?", explora los 9 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" es "1750" con 100%, lo que significa que el mercado asigna una probabilidad de 100% a ese resultado. El siguiente resultado más cercano es "1775" con 100%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.